Wilkinson EJ, Brown HM (2002) Vulvar paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar paget disease. Hum Pathol 33:549–554

Article  PubMed  Google Scholar 

Salamanca J, Benito A, García-Peñalver C, Azorín D, Ballestín C, Rodríguez-Peralto JL (2004) Paget’s disease of the glans penis secondary to transitional cell carcinoma of the bladder: a report of two cases and review of the literature. J Cutan Pathol 31:341–345

Article  PubMed  Google Scholar 

Brown HM, Wilkinson EJ (2005) Cytology of secondary vulvar Paget’s disease of urothelial origin: a case report. Acta Cytol 49:71–74

Article  PubMed  Google Scholar 

Kurashige Y, Minemura T, Nagatani T (2013) Paget phenomenon of the vulva with histopathological features of high-grade urothelial carcinoma (transitional cell carcinoma). Eur J Dermatol 23:556–557

Article  PubMed  Google Scholar 

Kiyohara T, Ito K (2013) Epidermotropic secondary extramammary Paget’s disease of the glans penis from retrograde lymphatic dissemination by transitional cell carcinoma of the bladder. J Dermatol 40:214–215

Article  PubMed  Google Scholar 

Gulavita P, Mai KT (2014) Urothelial bladder carcinoma metastasising to the scrotum mimicking primary extra-mammary Paget’s disease. Pathology 46:256–257

Article  PubMed  Google Scholar 

MartIn-Fuentes A, Sánchez-Herreros C, Cuevas-Santos J, De Eusebio-Murillo E (2015) Extramammary Paget disease secondary to a transitional cell carcinoma of the bladder. Indian J Dermatol Venereol Leprol 81:318–320

Article  PubMed  Google Scholar 

Qian YT, Ma DL (2018) Extramammary paget disease of the glans penis. CMAJ 190:E1142

Article  PubMed  PubMed Central  Google Scholar 

Chen YC, Wu CL, Lee JY (2018) Vulvar extramammary Paget’s disease secondary to urothelial carcinoma presenting with a small painful erosion of the vulva. Indian Dermatol Online J 9:471–473

Article  PubMed  PubMed Central  Google Scholar 

Nishikawa R, Honda M, Masago T, Morizane S, Hikita K, Takenaka A (2019) Extramammary Paget’s disease of the glans penis secondary to urethral recurrence of bladder carcinoma after radical cystectomy: a case report. IJU Case Rep 2:202–205

Article  PubMed  PubMed Central  Google Scholar 

Primo W, Primo GRP, Basilio DB, Machado KK, Carvalho JP, Carvalho FM (2019) Vulvar paget disease secondary to high-grade urothelial carcinoma with underlying massive vascular embolization and cervical involvement: case report of unusual presentation. Diagn Pathol 14:125

Article  PubMed  PubMed Central  Google Scholar 

Yamaura M, Yamada T, Watanabe R, Kawai H, Hirose S, Tajima H et al (2018) Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary paget disease, successfully treated with modified FOLFOX6: a case report. BMC Cancer 18:1142

Article  PubMed  PubMed Central  Google Scholar 

Yamamoto S, Shimomura T, Kasai K, Yamazaki T, Enei Y, Koike Y et al (2023) Pagetoid spread of urothelial carcinoma controlled without resection. IJU Case Rep 6:65–69

Article  PubMed  Google Scholar 

Powles T, Rosenberg JE, Sonpavde GP, Loriot Y, Durán I, Lee JL et al (2021) Enfortumab vedotin in previously treated advanced urothelial carcinoma. N Engl J Med 384:1125–1135

Article  PubMed  PubMed Central  Google Scholar 

Vlachou E, Johnson BA, McConkey D, Jing Y, Matoso A, Hahn NM et al (2024) Enfortumab vedotin-related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experience. Front Oncol 14:1377842

Article  PubMed  PubMed Central  Google Scholar 

Hashimoto H, Tanaka Y, Murata M, Ito T (2022) Nectin-4: a novel therapeutic target for skin cancers. Curr Treat Options Oncol 23:578–593

Article  PubMed  Google Scholar 

Lloyd J, Flanagan AM (2000) Mammary and extramammary Paget’s disease. J Clin Pathol 53:742–749

Article  PubMed  PubMed Central  Google Scholar 

Isrow D, Oregel KZ, Cortes J, Gomez H, Milikowski C, Feun L et al (2014) Advanced extramammary Paget’s disease of the groin, penis, and scrotum. Clin Med Insights Oncol 8:87–90

Article  PubMed  PubMed Central  Google Scholar 

Aoun F, El Rassy E, Kourie HR, Hawaux E, van Velthoven R (2015) Vulvar metastasis from bladder cancer. Case Rep Obstet Gynecol 2015:324634

PubMed  PubMed Central  Google Scholar 

Rosenberg J, Sridhar SS, Zhang J, Smith D, Ruether D, Flaig TW et al (2020) EV-101: a phase I study of single-agent enfortumab vedotin in patients with Nectin-4-positive solid tumors, including metastatic urothelial carcinoma. J Clin Oncol 38:1041–1049

Article  PubMed  PubMed Central  Google Scholar 

Chu CE, Sjöström M, Egusa EA, Gibb EA, Badura ML, Zhu J et al (2021) Heterogeneity in NECTIN4 expression across molecular subtypes of urothelial cancer mediates sensitivity to enfortumab vedotin. Clin Cancer Res 27:5123–5130

Article  PubMed  PubMed Central  Google Scholar 

Hoffman-Censits JH, Lombardo KA, Parimi V, Kamanda S, Choi W, Hahn NM et al (2021) Expression of Nectin-4 in bladder urothelial carcinoma, in morphologic variants, and nonurothelial histotypes. Appl Immunohistochem Mol Morphol 29:619–625

Article  PubMed  PubMed Central  Google Scholar 

Rodler S, Eismann L, Schlenker B, Casuscelli J, Brinkmann I, Sendelhofert A et al (2022) Expression of Nectin-4 in variant histologies of bladder cancer and its prognostic value-need for biomarker testing in high-risk patients? Cancers (Basel) 14:4411

Article  PubMed  Google Scholar 

Klümper N, Ralser DJ, Ellinger J, Roghmann F, Albrecht J, Below E et al (2023) Membranous NECTIN-4 expression frequently decreases during metastatic spread of urothelial Carcinoma and Is associated with enfortumab vedotin resistance. Clin Cancer Res 29:1496–1505

Article  PubMed  Google Scholar 

Murata M, Ito T, Tanaka Y, Kaku-Ito Y, Furue M (2020) NECTIN4 Expression in extramammary Paget’s disease: implication of a new therapeutic target. Int J Mol Sci 21:5891

Article  PubMed  PubMed Central  Google Scholar